Intrathecal chemotherapy for refractory disseminated medulloblastoma
- 5 December 2007
- journal article
- clinical trial
- Published by Springer Nature in Child's Nervous System
- Vol. 24 (5) , 581-585
Abstract
To analyze the effect of intrathecal (IT) chemotherapy for disseminated medulloblastoma.Keywords
This publication has 11 references indexed in Scilit:
- Treatment of Early Childhood Medulloblastoma by Postoperative Chemotherapy AloneNew England Journal of Medicine, 2005
- Intrathecal chemotherapy for patients with meningeal carcinomatosisSurgical Neurology, 2005
- Phase I Trial of Intrathecal Liposomal Cytarabine in Children With Neoplastic MeningitisJournal of Clinical Oncology, 2004
- Intrathecal Chemotherapy With Antineoplastic Agents in ChildrenPediatric Drugs, 2001
- Pharmacokinetics of Nimustine, Cytosine Arabinoside, and Methotrexate in Cerebrospinal Fluid during Cerebrospinal Fluid Perfusion Chemotherapy.Biological and Pharmaceutical Bulletin, 2001
- Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal disseminationJournal of Neuro-Oncology, 1998
- Ventriculolumbar Perfusion of 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea HydrochlorideNeurosurgery, 1993
- Intrathecal Chemotherapy for Leptomeningeal Dissemination of MedulloblastomaPediatric Neurosurgery, 1981
- Methotrexate: Distribution in Cerebrospinal Fluid after Intravenous, Ventricular and Lumbar InjectionsNew England Journal of Medicine, 1975
- Chemotherapy of primary malignant brain tumors in childrenCancer, 1975